According to the latest study titled ‘Bone Grafts and Substitutes Market Size, Share & Trends Analysis Report By Material Type ; By Application Type; By Region - Segment Forecast, 2020 – 2026’, available with Market Study Report, global bone grafts and substitutes market valuation is projected to reach USD 4.15 billion by the year 2026.
 

Rising pervasiveness of musculoskeletal ailments like psoriatic arthritis, rheumatoid arthritis, and osteoarthritis, especially among the geriatrics, in consort with increasing bone-related injuries & surgeries are majorly impelling the growth of global bone grafts and substitutes market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963748/
 

According to American Academy of Orthopedic Surgeons, the United States record around 3 million musculoskeletal interventions every year. Similarly, orthopedic procedures using bone grafts totaled to 2.2 million across the globe.
 

Shifting preference from autologous bone grafts to allografts, owing to delayed healing and complications associated with the former, along with easy availability of allografts in various shapes and sizes are augmenting the bone graft & substitutes industry outlook.
 

Notably, bone grafts are known for characteristics like osteoconduction, osteoinduction, osteogenesis, and structural support. Constant technological advancements and product innovations, setting up of new specialty orthopedic clinics, and favorable medical insurance scenario are boosting the worldwide bone grafts and substitutes market revenues. Also, booming population, improved disposable incomes, rising cognizance about appearance, and preference for technologically sophisticated procedures are stimulating the business scenario.
 

However, high cost of bone graft operations, alongside complications associated with them, and deceptive marketing methods will pose as challenge for the market partakers.
 

Different material type for bone grafts and substitutes are synthetic, and natural. While the application areas include long bone, craniomaxillofacial, and spinal fusion.
 

From regional frame of reference, North America account for 38% share of global bone graft and substitutes industry in 2019 and is reckoned to bolster significantly over the analysis timeframe. The lucrative growth trends can be credited to increasing patient pool with orthopedic condition, and rising trauma-relation accidents.
 

Market colossuses profiled in the report are Biobank, TBF Tissue Engineering, Geistlich Pharma AG, Zimmer Biomet, OST Développement, Wright Medical Group N.V., Baxter International Inc., Smith & Nephew plc, AlloSource Inc., NuVasive Inc., Stryker Corp., Medtronic plc, DePuy Synthes Inc., and Orthofix Holdings Inc.